What is Gendron?
Gendron designs and manufactures essential medical equipment tailored for bariatric patient care, serving diverse environments such as home care, long-term care facilities, rehabilitation centers, and acute care settings. Their comprehensive product line includes bariatric beds, mobility aids, transfer and transport solutions, seating, and personal care items, all engineered to address the specific comfort and safety needs of bariatric individuals. As a trademark of GF Health Products, Inc., Gendron operates under ISO 13485 certification, ensuring high standards in medical device manufacturing. The company's focus on this underserved patient demographic positions it as a key provider of specialized healthcare solutions.
How much funding has Gendron raised?
Gendron has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Gendron
PPP
Public-Private Partnership
What's next for Gendron?
With the recent influx of major strategic investment, Gendron is poised for significant expansion and innovation. This substantial backing, part of its large-scale late-stage funding, will likely fuel advancements in product design, manufacturing capacity, and market reach. The company is expected to further solidify its leadership in the bariatric medical equipment sector, potentially exploring new product lines or enhancing existing ones to meet evolving patient and provider demands. Strategic partnerships and technological integration may also be key components of Gendron's forward trajectory, aiming to improve patient outcomes and operational efficiencies across the healthcare continuum.
See full Gendron company page
